Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102516300A discloses efficient phosphine ligands enabling superior enantioselectivity and simplified synthesis for cost-effective pharmaceutical intermediate manufacturing.
Patent CN105111228A reveals a novel 5,5'-tetralone chiral phosphoric acid with superior acidity and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Patent CN112920053B reveals a scalable, high-purity route for chiral amines used in asthma and oncology APIs, offering significant cost and safety advantages.
Patent CN112209947A details a mild organocatalytic route for chiral indoxazinones, offering high enantioselectivity and cost reduction in API manufacturing.
Patent CN115155658B details a novel one-pot synthesis for VAPOL-based selenium-sulfur catalysts, offering cost-effective solutions for asymmetric organic manufacturing.
Discover a novel metal-free organocatalytic route to axially chiral 1-aryl indoles. High optical purity, mild conditions, and scalable synthesis for glioma inhibitors.
Novel chiral phosphoric acid catalyzed synthesis of axially chiral indole-naphthalene compounds. High enantioselectivity, mild conditions, scalable for API manufacturing.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for chiral catalyst precursors and pharmaceutical intermediates.
Novel route for C2-symmetric diamines using tert-butylsulfinamide. High yield, scalable process for pharma intermediates.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Discover the novel organocatalytic synthesis of N-N axis chiral bisindoles via patent CN116082217B. High enantioselectivity and cytotoxic activity for advanced drug development.
Patent CN105294599B details a novel catalytic asymmetric synthesis for chiral thiadiazine diuretics. This method offers significant supply chain and cost advantages for pharmaceutical manufacturers.
Patent CN118878543A reveals high-purity axial chiral synthesis. Delivers significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN108409615B discloses a green route for chiral sulfinamides, eliminating liquid ammonia usage and enhancing yield for reliable pharmaceutical intermediate supply chains.
Novel copper-catalyzed synthesis achieves >99% purity with mild conditions, enhancing supply chain reliability for oncology drug development.
Discover how this novel chiral catalyst enables 99% ee synthesis with 90% yield, reducing R&D costs and supply chain risks for oncology drug development.
Reduce production costs and environmental impact with >98% ee and 92% yield in asymmetric synthesis of key florfenicol intermediate for pharmaceutical manufacturing.
Discover efficient chiral indolo-dihydropyridoindole synthesis with 96% yield and 95% ee. Ideal for pharmaceutical R&D and cancer drug development. Scale up with CDMO expertise.
Discover how new asymmetric synthesis of (S,S)-2,8-diazabicyclononane reduces costs and steps for moxifloxacin production, ensuring supply chain stability.